Show All
Practitioner
Consumer

NanaBis demonstrates continued improvement in pain scores
The first cohort of Observational Study patients completing 12-month treatment with NanaBis™ demonstrated continued improvement in pain scores.

Medlab to be granted European patent for NanoCelle® drug delivery platform
European Patent Office issues Notice of Intention to grant Medlab Clinical patent for NanoCelle® drug delivery platform

Novartis’ Managing Director of Oncology (ANZ/NZ) joins Medlab Clinical board
Medlab Clinical appoints Novartis' Managing Director of Oncology for Australia and New Zealand as Non-Executive Director.

Medlab Clinical raises $15 million and Leading Executive Joins Board
Medlab Clinical successfully raised $15 million via a two-tranche placement.